Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 24;61(1):69.
doi: 10.1186/s42358-021-00219-y.

Brazilian Society of Rheumatology 2020 guidelines for psoriatic arthritis

Sueli Carneiro  1 , Penelope Esther Palominos  2 , Sônia Maria Alvarenga Anti  3 , Rodrigo Luppino Assad  4 , Rafaela Silva Guimarães Gonçalves  5 , Adriano Chiereghin  6 , Andre Marun Lyrio  7 , Antônio Carlos Ximenes  8 , Carla Gonçalves Saad  9 , Célio Roberto Gonçalves  9 , Charles Lubianca Kohem  2 , Cláudia Diniz Lopes Marques  5 , Cláudia Goldenstein Schainberg  9 , Eduardo de Souza Meirelles  9 , Gustavo Gomes Resende  10 , Lenise Brandao Pieruccetti  11 , Mauro Waldemar Keiserman  12 , Michel Alexandre Yazbek  13 , Percival Degrava Sampaio-Barros  9 , Ricardo da Cruz Lage  10 , Rubens Bonfiglioli  7 , Thauana Luíza Oliveira  14 , Valderílio Feijó Azevedo  15 , Washington Alves Bianchi  16 , Wanderley Marques Bernardo  9 , Ricardo Dos Santos Simões  17 , Marcelo de Medeiros Pinheiro  14 , Cristiano Barbosa Campanholo  18
Affiliations

Brazilian Society of Rheumatology 2020 guidelines for psoriatic arthritis

Sueli Carneiro et al. Adv Rheumatol. .

Abstract

Psoriatic arthritis (PsA) is a chronic and systemic immune disease characterized by inflammation of peripheral and/or axial joints and entheses in patients with psoriasis (PsO). Extra-articular and extracutaneous manifestations and numerous comorbidities can also be present. These recommendations replace the previous version published in May 2013. A systematic review of the literature retrieved 191 articles that were used to formulate 12 recommendations in response to 12 clinical questions, divided into 4 sections: diagnosis, non-pharmacological treatment, conventional drug therapy and biologic therapy. These guidelines provide evidence-based information on the clinical management for PsA patients. For each recommendation, the level of evidence (highest available), degree of strength (Oxford) and degree of expert agreement (interrater reliability) are reported.

Keywords: Guideline; Inflammation; Psoriatic arthritis; Spondyloarthropathies; Treatment.

PubMed Disclaimer

References

    1. Scotti L, Franchi M, Marchesoni A, Corrao G. Prevalence and incidence of psoriatic arthritis: a systematic review and meta-analysis. Semin Arthritis Rheum. 2018;48(1):28–34. https://doi.org/10.1016/j.semarthrit.2018.01.003 . - DOI - PubMed
    1. Alinaghi F, Calov M, Kristensen LE, et al. Prevalence of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational and clinical studies. J Am Acad Dermatol. 2019;80(1):251–65. https://doi.org/10.1016/j.jaad.2018.06.027 . - DOI
    1. Ranza R, Carneiro S, Qureshi AA, et al. Prevalence of psoriatic arthritis in a large cohort of Brazilian patients with psoriasis. J Rheumatol. 2015;42(5):829–34. https://doi.org/10.3899/jrheum.140474 . - DOI - PubMed
    1. Scarpa R, Cosentini E, Manguso F, et al. Clinical and genetic aspects of psoriatic arthritis “sine psoriasis.” J Rheumatol. 2003;30(12):2638–40. - PubMed
    1. Poggenborg RP, Østergaard M, Terslev L. Imaging in psoriatic arthritis. Rheum Dis Clin North Am. 2015;41(4):593–613. https://doi.org/10.1016/j.rdc.2015.07.007 . - DOI - PubMed

Publication types